Table 1.
Group | Ach (pg/L) | NO (μmol/L) | VIP (pg/L) | SP (pg/L) |
---|---|---|---|---|
blank | 38.17 ± 10.17 # | 30.71 ± 3.81 | 18.19 ± 3.75 ## | 31.97 ± 12.81 |
model | 27.82 ± 7.28 * | 26.99 ± 4.77 | 26.19 ± 4.53 ** | 24.76 ± 6.23 |
Tag-H | 37.98 ± 11.58 # | 15.60 ± 2.76 *,## | 24.07 ± 2.50 | 49.11 ± 11.25 ## |
Blank group (days 1–14, distilled water administration period and days 15–28, distilled water administration period); model group (days 1–14, induction of constipation period and days 15–28, distilled water administration period); and tagatose group (days 1–14, induction of constipation period and days 15–28, tagatose administration period). Tag-H, mice treated with 1.70 g/kg BW tagatose). *, compared with the blank group, p < 0.05; **, compared with the blank group, p < 0.01; #, compared with the model group, p < 0.05; and ##, compared with the model group, p < 0.01. Acetylcholine (Ach); nitric oxide (NO); substance P (SP); vasoactive intestinal peptide (VIP).